The Muscle Question With GLP-1 Medications

---

GLP-1 based medications such as semaglutide and tirzepatide are FDA-approved for chronic weight management in eligible adults. When weight comes down, however, not all of it is fat. In clinical trials that measured body composition with DXA scans, roughly 28–33% of the weight lost on a GLP-1 alone was classified as lean mass.

Lean mass is not the same thing as muscle. It also includes water, organ tissue and connective tissue, so researchers are still working out how much of this change is truly muscle and whether it affects strength or function. That open question is why some investigators are asking whether a second drug could change the balance.

What Is Myostatin?

---

Myostatin is a protein made mainly in skeletal muscle that acts as a natural brake on muscle growth. Drugs that interfere with this signaling are being studied in several conditions. They fall into two broad groups:

• Selective myostatin antibodies (for example apitegromab and trevogrumab) target myostatin or the pathway that activates it.
• Broader activin receptor blockers (for example bimagrumab) block the receptor that several related proteins use, so their effects reach beyond myostatin alone.

The Theory in Three Steps

---

This is a hypothesis under study, not an established benefit.

What the Research Shows So Far

---

All of the studies below are phase 2 trials, and most were sponsored by the companies developing the drugs. They are early signals, not proof.

Potential Upsides vs. Concerns

---

Swipe sideways on small screens to see the full table.

Regulatory & Medical Status: Why This Is Theoretical

---

Safety & Research Considerations

---

Important Safety Information

Myostatin pathway inhibitors are investigational. Their full safety profile is not known.

• Reported in trials: muscle spasms, diarrhea and acne, with more participants stopping treatment in some bimagrumab groups.
• The triple-drug COURAGE arm (including garetosmab) had a higher rate of side effects than other arms.
• Because these drugs act on pathways beyond muscle, long-term effects are not yet understood.
• GLP-1 medications such as semaglutide and tirzepatide carry a boxed warning for the risk of thyroid C-cell tumors. See our overview of weight loss medication options.
• Do not buy “research use only” products online. They are not approved for human use, and their purity and dosing are unverified.
• Do not combine medications on your own. Talk with a licensed clinician about any weight loss medication.
• Trials are listed on ClinicalTrials.gov (for example NCT05616013, NCT06445075, NCT06299098).

Considerations for Ongoing Research

• Function vs. scans: do improvements on DXA translate into better strength, mobility or quality of life?
• Longer follow-up: most data covers 24–72 weeks.
• After stopping: what happens to muscle, fat and weight when treatment ends?
• Who benefits: older adults, people with low baseline muscle, or others may respond differently.
• Compared with lifestyle: how do these drugs compare with resistance training and adequate protein?
• Broad vs. selective blockade: do narrower drugs offer a better balance of benefit and side effects?

Important Disclaimer

This article is for general educational purposes only and does not constitute medical advice. It does not establish a patient relationship and should not be used to diagnose, treat or make decisions about any condition. Discuss any medication question with a licensed healthcare provider. Research findings may change as new data is published.

Sources

1. BELIEVE trial, Nature Medicine

2. EMBRAZE trial, Nature Medicine

3. Regeneron: COURAGE phase 2 results (press release)

4. Review article, PubMed Central

5. Medscape: BELIEVE coverage

6. Medscape: EMBRAZE coverage

7. Medscape: COURAGE coverage

8. ADA 2025 conference summary (Cipla Medical)

9. Bimagrumab COPD trial, eScholarship

10. Scholar Rock: FDA review of apitegromab (press release)

11. Patient Care: BELIEVE summary

12. Obesity and Endocrinology, 2026 (Oxford Academic)

Peptides and Brain Health: What the Research Shows

Published 10/6/2026

Traumatic brain injury (TBI), repeated head impacts such as those linked to chronic traumatic encephalopathy (CTE), and age-related memory and thinking changes are among the hardest problems in medicine. Researchers have been exploring a number of peptides in this area, including Semax, Selank, Cerebrolysin, and Dihexa. This article explains what each one is, what has been studied, and, just as importantly, what has not been shown.

At a Glance

Explore the Topic

Open any section below to learn more.

Why brain injury and neurodegeneration are hard research problems
▼

Traumatic brain injury (TBI), repeated head impacts, and age-related cognitive conditions each involve complex, overlapping biology, including inflammation, disrupted nerve-cell signaling, and loss of connections between neurons. Chronic traumatic encephalopathy (CTE) is currently diagnosed definitively only by examining brain tissue after death.

Because of this complexity, researchers are exploring many different approaches, including peptides. Most of that work is early, and none of the peptides discussed here is FDA-approved to treat, prevent, or diagnose any brain injury or neurodegenerative condition.

Semax
▼

Semax is a synthetic peptide related to a fragment of adrenocorticotropic hormone (ACTH), developed in Russia. In rat studies, it changed the expression of brain-derived neurotrophic factor (BDNF) and its receptor trkB in the hippocampus, a brain region involved in learning and memory^[2].

That is a laboratory finding about gene and protein expression in rats. It does not show that Semax improves memory, protects the brain, or helps any condition in people. In the sources we reviewed, we did not find large, independently replicated randomized trials in Western populations.

Selank
▼

Selank is a synthetic peptide related to tuftsin, a fragment of an immune protein, also developed in Russia. In a rat study, Selank and the neurotransmitter GABA changed the expression of many of the same genes in the frontal cortex, with a strong correlation between the two at one hour (r=0.86). The authors suggested this may reflect an allosteric effect on GABA receptors, and noted that the full mechanism needs further study^[1].

As with Semax, this is early mechanistic work in animals. It does not establish an effect on mood, anxiety, cognition, or any condition in people.

Cerebrolysin
▼

Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pig brain tissue, given by intravenous infusion. It is the most clinically studied item on this page, and it is not FDA-approved.

Traumatic brain injury: a prospective meta-analysis of two phase IIIb/IV randomized, double-blind, placebo-controlled trials (185 patients with moderate to severe TBI) reported a small-to-medium effect on a combined set of functional and neuropsychological scales at day 30 (p=0.0156) and day 90 (p=0.0146), with comparable safety to placebo^[5]. One of those trials, the 46-patient CAPTAIN I study, narrowly missed significance on its primary analysis, and its authors recommended larger trials.

Vascular dementia: a Cochrane review of six randomized trials (597 participants) found improved cognition and general function with Cerebrolysin, but rated all of the evidence as very low quality and called the supporting evidence base weak. The authors noted the effects may lack clinical meaningfulness. This review covers vascular dementia, not Alzheimer’s disease^[4].

Dihexa
▼

Dihexa is a synthetic peptide derived from angiotensin IV and chemically modified for stability. In a 2013 study, it showed activity in rat models of induced memory impairment and increased synapse formation in laboratory preparations. The authors proposed it as a candidate for further development^[3].

We are not aware of controlled human trials. Findings in rodents frequently do not translate to people, and Dihexa remains an investigational research compound.

Other peptides in early research
▼

Other peptides, including BPC-157 and thymosin beta-4, have appeared in early animal research involving nervous-system injury. We did not review that literature for this article, the evidence is preclinical, and neither is approved for any brain-related use. See our BPC-157 vs. TB-500 article for what is and is not known about them.

What the evidence can — and can’t — tell us
▼

What has been found	What is still unknown
Semax, Selank, and Dihexa have been studied in rodents or cell models[1][2][3].	Whether any of those effects occur in people, or lead to a meaningful outcome.
Cerebrolysin has been tested in small randomized trials in TBI and vascular dementia[4][5].	Whether results hold in larger, independent trials. The Cochrane review rated the evidence very low quality[4].
Brain injury and dementia involve many biological pathways.	Whether any peptide can affect the course of CTE, TBI recovery, or Alzheimer’s disease. No peptide discussed here is approved for those uses.

Regulatory status
▼

None of the peptides discussed here is FDA-approved. Semax, Selank, and Dihexa are listed in our FDA Peptide Review as slated for FDA advisory committee review in 2027, with no committee recommendation yet. Compounded drugs are made by licensed pharmacies for individual patients and have not been evaluated by the FDA for safety, effectiveness, or quality.

Regulatory decisions can change as the FDA completes its review process. We track developments in the FDA Peptide Review.

Safety Considerations
▼

• Head injury is a medical emergency when severe. Seek immediate care for loss of consciousness, repeated vomiting, worsening headache, confusion, seizures, weakness, or unusual drowsiness after a blow to the head. Do not substitute any peptide for evaluation.
• Memory or thinking changes have many possible causes, some treatable. A licensed clinician should evaluate them.
• Not FDA-approved: safety and effectiveness for brain-related uses have not been established through FDA review.
• Limited human data: for Semax, Selank, and Dihexa, the sources we reviewed are laboratory and animal studies. Long-term safety in people is unknown.
• Cerebrolysin is an infused animal-derived product given under medical supervision. The trials cited here reported safety comparable to placebo, but they were small^[4][5].
• “Research Use Only” and unlicensed sources carry risks of wrong contents, wrong dose, contamination, or no sterility testing.
• Pregnancy, breastfeeding, and other medicines: there is no established safety data. Tell your clinician about all medications and supplements you take, especially those affecting the brain or mood.

Our Perspective

This section is editorial. Brain health is a topic where hope runs ahead of evidence, and we think patients deserve a clear picture of both. If you come across any of these peptides from any source, we suggest asking three questions:

1. What is the evidence, in people? Ask which study supports the claim, how large it was, and whether it was in humans or animals.
2. What is its regulatory status, and who prepared it?
3. Has the underlying problem been properly evaluated? Memory changes and post-injury symptoms need a clinical workup first.

Referenced Research

Peptides Explained

Tiny Chemical Messengers, Explained Clearly

Peptides are short chains of amino acids. Many well-known hormones are peptides, including insulin, oxytocin, and GLP-1-based medications like Ozempic. Think of amino acids as the letters of the biological alphabet: a peptide is a short word, while a protein is a full sentence or paragraph.

Because peptides are smaller than proteins, they move through the body more easily and bind to specific receptors on cells, signaling those cells to perform certain functions. Below is an overview of some of the peptides discussed most often in our clinic, focused on how each one works at a biological level.

Safety Considerations
▼

Peptides are bioactive substances, and each carries its own considerations. In general:

• Many peptides discussed on this page are compounded and are not FDA-approved for the uses described; some are not currently legal for U.S. pharmacies to compound pending FDA rule-making.
• Individual side effects, interactions, and contraindications vary by peptide and by patient — your provider will review these with you individually before starting any therapy.
• Peptides sourced outside of licensed, tested compounding pharmacies (including anything labeled “Research Use Only”) carry meaningfully higher risk of contamination, incorrect dosing, and lack of sterility testing.
• Pregnant or breastfeeding patients, and patients with active cancer or a history of cancer, should discuss any peptide therapy carefully with their provider given limited long-term safety data for many of these substances.

Seek emergency care immediately for any signs of a severe allergic reaction, including hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.

This article is for informational and educational purposes only and is not a substitute for medical advice. Statements have not been evaluated by the FDA. See our full disclosures for details on compounding, FDA approval status, and the doctor-patient relationship.

FDA Considering Reclassifying 14 Restricted Peptides

• During its high-stakes meeting on July 23–24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) narrowly voted to recommend adding six of the seven reviewed peptides to the Section 503A Bulk Drug Substances List.
• This narrow vote directly opposed the recommendation of the FDA’s own staff scientists, who advised against inclusion for all seven, citing a lack of robust human safety and clinical data.
• The panel’s task was to determine whether licensed compounding pharmacies should be permitted to custom-manufacture specific unapproved peptides.

July 2026 PCAC Peptide Recommendations

Recommendation Status	Peptide Name	Common Uses / Proposed Indications
Recommended for 503A List (Voted to Allow Compounding)	BPC-157	Tissue healing, gut health, joint repair
	TB-500 (Thymosin Beta-4)	Wound healing, muscle recovery, inflammation
	KPV	Anti-inflammatory, antimicrobial, gut health
	MOTS-c	Mitochondrial function, metabolic health, energy
	Semax	Cognitive enhancement, neuroprotection, focus
	Epitalon	Anti-aging, longevity, sleep regulation
Ruled Against (Rejected for Compounding)	Emideltide (DSIP)	Chronic pain, sleep disorders, opioid withdrawal

Supporters, including HHS Secretary Robert F. Kennedy Jr., pushed for the expansion as a way to transition users away from an unregulated, gray-market online landscape of unverified “research grade” imports.

What Does This Mean, Exactly?

• The PCAC’s vote is non-binding and advisory only. It remains currently illegal for U.S. pharmacies to compound these six substances until the FDA completes formal rule-making. We see this as a positive step — not a determinate legal outcome, but a sign the current administration is willing to directly confront the black- and gray-market landscape.
• Complete addition to the 503A Bulks List requires formal administrative rule-making and final sign-off from the HHS Secretary, which typically takes significant time. A second PCAC meeting has already been scheduled to review the remaining peptides on Secretary Kennedy’s original list of 14.

Original publication date: 4/14/2026

The FDA is formally reviewing whether to reclassify up to 14 peptides restricted under Category 2 in late 2023. The review involves a series of public PCAC meetings — the first held in July 2026, with a second scheduled for 2027 — to determine whether these substances should return to Category 1, allowing routine compounding by Section 503A pharmacies.

While an official final list is still pending, the following peptides have been named for review, per statements from HHS Secretary Robert F. Kennedy Jr.:

Peptides Reviewed in July 2026

• BPC-157: studied for tissue repair, gut healing (including ulcerative colitis), and inflammation reduction.
• TB-500 (Thymosin Beta-4 fragment): studied for muscle repair, wound healing, and recovery.
• KPV: an anti-inflammatory peptide studied for wound healing and gut health.
• MOTS-c: a mitochondrial peptide studied for metabolic regulation, obesity, and osteoporosis.
• Emideltide (DSIP): studied for opioid withdrawal, chronic insomnia, and narcolepsy. (Not recommended by the PCAC.)
• Semax: a neuropeptide studied for cognitive function, migraine relief, and circulatory issues.
• Epitalon: studied for its effects on sleep and aging-related processes.

Peptides Slated for 2027 Review

• Thymosin Alpha-1 (Tα1): studied for immune system modulation.
• GHK-Cu (Copper Peptide): studied for skin health and wound healing.
• CJC-1295: a growth hormone-releasing peptide studied for metabolism and muscle support.
• Ipamorelin: often studied alongside CJC-1295 for natural growth hormone stimulation.
• Selank: a neuropeptide studied for anxiety management and neuroprotection.
• Cathelicidin (LL-37): studied for antimicrobial and wound-healing properties.
• Dihexa Acetate: studied for cognitive health and neuroprotection.
• AOD-9604: a fragment of human growth hormone studied for fat metabolism.

What This Means for Patients Currently Using Compounded Peptides

To be clear, most of these peptides are currently available only through sterile compounding pharmacies holding special licenses for sterile — and in some cases biologic — compounding. A recent USP General Chapter <797> update outlined requirements for injectable compounds, including beyond-use dates, storage requirements, and compounding specifications.

All pharmacies that manufacture any compound must source their active pharmaceutical ingredient (API) from a verified USP provider or importer to ensure safety and sterility.

Below are some of the compliance standards API sourcing companies must meet to supply U.S. compounding pharmacies:

• FDA Registration: the manufacturer must be registered with the FDA under Section 510.
• Monograph Compliance: where a USP/NF monograph exists for a substance, the bulk material must strictly comply with those standards.
• Exclusion of “Research Use Only” (RUO) Material: pharmacies are prohibited from sourcing peptides labeled for research use only, since these don’t meet the clinical-grade standards required for human — especially sterile injectable — administration.

The compounding pharmacies we work with perform extensive third-party testing on each manufactured batch: raw material is tested before compounding, and the formulated product is tested again before reaching patients. Each batch of sterile injectable medication must meet baseline safety standards, typically verified through:

• Sterility Testing: the primary defense against microbial contamination, incubating samples to detect bacteria or fungi. 503B facilities must test every batch before release; beyond-use dates are also tested for storage, temperature, and shelf life.
• Endotoxin Testing: targets pyrogens — microbial byproducts that can cause severe fever or shock if injected. Mandatory for all 503B products and for 503A high-risk compounds made from non-sterile starting ingredients.
• Potency Testing: confirms the active ingredient’s concentration matches the label exactly. Required for every 503B batch; most 503A pharmacies also perform this voluntarily for dosing consistency.
• Particulate Matter Inspection: a visual or automated check confirming the liquid is clear and free of visible fibers, glass shards, or undissolved precipitates.

These rules apply only to peptides and compounds produced by U.S.-based, licensed compounding pharmacies — not to “research use only” or black-market products, which are sold and labeled “Not for Human Use” as a loophole rather than a genuine research safeguard. At MedClub, we support the FDA’s current review process. There’s significant demand for these compounds paired with limited patient education, and high demand with short legal supply tends to fuel a robust black market — most people don’t realize they’re risking exposure to dangerous bacteria and endotoxins when injecting a product purchased online under a “Research Use Only” label. We’ve seen peptides support meaningful patient outcomes across a range of concerns, and we want to keep offering that while giving patients confidence that what we source and use meets the highest available safety standards.

 

 

We’ll update this article as new information becomes available. Stay tuned.

This article reflects the status of FDA regulatory proceedings as of the dates noted above — this is an evolving situation and details may change. The “Our Opinion” section reflects MedClub’s own editorial perspective, not a statement of fact or FDA policy. None of the peptides discussed here are FDA-approved, and none may currently be legally compounded by U.S. pharmacies unless and until the FDA completes formal rule-making.

HCG vs. Enclomiphene: Protecting Your Natural Testosterone Production During TRT

At MedClub, we get this question often — usually because guys have been on HCG (Pregnyl/Novarel) for a while and are tired of subcutaneous injections, or because of the cost, since Pregnyl isn’t cheap. Below is a pro/con breakdown of the differences, along with our professional take.

Why You Shouldn’t Take Testosterone by Itself

The answer is safety, longevity, and preserving your body’s ability to continue its natural systems in the face of atrophy. TRT creates a negative feedback loop in the Hypothalamic-Pituitary-Gonadal (HPG) axis which, if left unchecked, can cause permanent atrophy.

 

 

Pregnyl/Novarel (HCG) Microdoses

Pros:

• Direct Stimulation: Acts as a luteinizing hormone (LH) mimic, directly telling the testes to produce testosterone and sperm even while TRT is “shutting them down.”
• Maintains Testicular Size: Most effective for preventing or reversing testicular atrophy (shrinkage), or for PCT in non-medical situations.
• Well-Studied for TRT: Widely considered the “gold standard” for guys wanting to stay fertile while on therapy, and to protect against the negative feedback loop.

Cons:

• Injections: Requires frequent subcutaneous injections, which may be a hassle.
• Estrogen Spikes: Can significantly increase aromatization (estrogen levels), sometimes leading to nipple sensitivity or water retention.
• Cost & Storage: Much more expensive than clomiphene/enclomiphene and requires refrigeration after mixing.

Clomiphene or Compounded Enclomiphene

Pros:

• Oral Convenience: A simple pill taken daily or a few times a week — no shots.
• Inexpensive: Significantly cheaper than HCG and more widely available as a generic or custom-compounded tablet/capsule.
• Natural Signal: Encourages your brain to send its own signals to the testes via the FSH pathway — it does not signal LH directly.

Cons:

• Potentially Blocked by TRT: If your TRT dose is high, it may completely overpower clomiphene’s signal to the brain, making it ineffective while on therapy.
• Emotional Side Effects: Some men report brain fog, mood swings, or a flattening of emotions.
• Vision Risks: In rare cases, it can cause floaters or blurred vision, which usually requires stopping the drug altogether.
• Paradoxical Libido: Some guys will see their T-levels rise on paper but experience a decrease in libido or sexual function.

We treat testicular hypofunction and long-term testosterone supplementation, so our approach is designed specifically for men’s longevity — not bodybuilding. A bodybuilding-level dosage protocol is too high for any HPG-axis-related agonist to meaningfully protect against androgenic negative feedback, so this discussion does not apply to that context and isn’t written as a solution for it.

What About Gonadorelin?

GnRH looks great on paper and in theory, but in our experience we’ve seen consistently negative feedback from patients who’ve used it — shrunken testes, low sperm count, low volume, low libido, and a range of other side effects. It gained popularity after HCG’s compounding availability was restricted a few years ago, prompting some clinics to look for alternatives rather than switch to Pregnyl/Novarel. HCG is derived from the urine of pregnant women, which is part of why its sourcing and chain of custody are held to strict standards. Some patients likely do fine on gonadorelin, but based on what we’ve seen, those same patients would likely do just as well on enclomiphene — which is less expensive and more widely available. The importance of individualized dosing can’t be overstated.

Important Disclosures

This article reflects the clinical opinion and experience of our providers and is provided for general educational purposes only. It is not medical advice, and it is not a substitute for a one-on-one evaluation. TRT and related hormone therapies are prescription treatments requiring an in-person medical evaluation and ongoing physician oversight; MedClub’s telehealth model applies to vitamins and peptide therapies, not to testosterone or other controlled substances.

Individual results and appropriate treatment vary by patient. Compounded medications discussed here are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.

Testosterone in MCT Oil: Pros and Cons

Testosterone replacement therapy (TRT) has become an increasingly common and effective treatment for men experiencing symptoms of low testosterone — fatigue, low libido, weight gain, and muscle loss. While several delivery methods exist (injections, gels, pellets, patches), many compounding pharmacies now offer testosterone suspended in MCT oil (medium-chain triglyceride oil) as a customizable injection option. Let’s explore the pros and cons.

Pros of Testosterone in MCT Oil

1. Reduced Injection Pain: MCT oil is a thinner, smoother carrier compared to sesame or cottonseed oil. Many patients report less injection-site discomfort, making it a preferred option for long-term therapy.
2. Better Absorption: MCTs are metabolized quickly and efficiently by the body, which can support more consistent absorption and stable hormone levels over time.
3. Customizable Dosing: Compounded testosterone in MCT oil allows for custom strengths and concentrations, enabling precise titration based on your individual hormone levels, goals, and symptoms.
4. Lower Allergenic Potential: Some patients react to traditional carriers like sesame or grapeseed oil. MCT oil is less likely to trigger allergic responses, especially in sensitive individuals.
5. Improved Shelf Stability: MCT oil is less prone to oxidation than some other oils, which can extend shelf life and help maintain potency.

Cons of Testosterone in MCT Oil

1. Not FDA-Approved: Compounded medications, including testosterone in MCT oil, are not FDA-approved and are not subject to the same manufacturing oversight as commercial products. Quality depends entirely on the compounding pharmacy — it’s important to choose a provider with longstanding relationships with trusted, accountable compounders.
2. Injection Technique Matters: Because MCT oil is thinner, improper technique (injecting too fast, or into the wrong tissue) can cause irritation or oily leakage. A minimum depth of 1/2″ and a slow, controlled plunge speed help minimize this.
3. Dosing Frequency Varies: Some patients achieve stable levels with once-weekly injections; others need 2–3 injections weekly to prevent fluctuations. Thinner oil flows more easily through a thinner-gauge needle, which can make more frequent injections more comfortable.
4. Limited Availability: Not all pharmacies compound testosterone in MCT oil. Patients may need specialty or telemedicine-affiliated pharmacies, which can mean longer shipping times or limited access depending on location. At MedClub, we work with a network of compounding pharmacies and can source most types of testosterone and nandrolones in MCT oil on request.
5. Cost May Vary: Compounded testosterone is usually priced close to brand-name or generic options, though specialty blends can run a bit higher. Most patients pay out of pocket or use an HSA/FSA rather than traditional insurance. Expect roughly $100 per 10mL vial, though pricing can vary.

Is Testosterone in MCT Oil Better for Subcutaneous Injections?

A subcutaneous (SubQ) injection delivers medication into the fatty tissue just beneath the skin, allowing for slower, more sustained absorption than deeper intramuscular injections. It’s commonly used for insulin, hormone therapies, peptides, and certain vaccines.

For some time, we’ve discouraged patients from administering testosterone via SubQ, for a few reasons. First, legally, providers cannot recommend a delivery method that isn’t officially approved. Second, more practically: grapeseed, cottonseed, and sesame oil are thick and difficult to draw into a thin, “insulin-style” needle — the draw is slow, bubbles form from the vacuum force required, and it’s time-consuming. Third, granuloma formation is a real risk: small, firm areas of inflammation can form under the skin in response to injected substances the body perceives as foreign or irritating.

There is one FDA-approved brand-name injection reconstituted into a bacteriostatic water solution — essentially a “water-based” testosterone shot delivered via auto-injector pen. Compounding pharmacies cannot produce a generic version of this specific product due to an active patent.

In our own clinical testing of the newer compounded MCT oil, we found that even though it’s noticeably thinner than traditional carrier oils, it still takes considerable time to draw and push through a 31-gauge needle. We tested four needle sizes — 31G 5/16″, 30G 1/2″, 30G 5/16″, and 29G 1/2″ — to determine which performed best for SubQ administration of this thinner oil. The 5/16″ lengths proved too short, causing leakage more often than not, even with a slower plunge. The 30G and 29G 1/2″ needles performed best for small “micro-dose” injections of 0.1–0.25mL, administered multiple times weekly under provider guidance. The 30G 1/2″ was slightly more comfortable, though supply chain issues can sometimes make it harder to source.

We found the abdomen to be the most effective injection site for patients with sufficient fat to tolerate a 1/2″ depth (roughly 15%+ body fat); for leaner patients, the upper arm, gluteus medius, or quadricep areas worked well. Site selection often comes down to a patient’s ability to reach the area comfortably and perform sterile technique correctly. Most patients who explore SubQ do so to spread one large weekly dose into several smaller micro-doses — for side-effect management, therapeutic balance, or needle sensitivity. If you’re considering SubQ purely because you assume it’s less painful: that’s relative. Icing the injection site before cleaning with alcohol numbs the top layer of skin effectively, which is often what resolves needle anxiety after a few comfortable experiences.

Frequently Asked Questions

What’s the MedClub vibe like?
▼

MedClub is a family-owned boutique concierge medicine clinic. We’ve been operating in this field for 10+ years with thousands of satisfied patients, blending clinical expertise with a family-like environment. We’re not sales-people — our patients return because we’ve earned their trust over many years.

What does the TRT membership cover?
▼

We keep it straightforward: $300 covers your initial labs, initial consultation, supplies, training, and first month of oversight. If you bring recent labs of your own, your initial consultation is $150 instead.

After your first month, membership is $89/month, covering ongoing oversight and unlimited follow-ups, plan changes, consultations, and prescribing. Patients pay for medications directly at the pharmacy — this keeps things transparent and doesn’t limit you to one pharmacy or brand.

Labs can be forwarded from your primary care provider annually, or purchased through us anytime. Most patients choose our Men’s Hormone Panel (general chemistry plus bioavailable hormones), priced at $150 if drawn at Quest Diagnostics. For more advanced testing — genetic testing, gut chemistry, and similar — we’ll build a custom analysis and provide pricing before you decide.

Will I be bounced around to different providers?
▼

No — Dr. Jenn and her clinical director handle each patient personally. We won’t hand you off to another provider after your first visit. You’ll get to know us, and we’ll get to know you, hopefully for years to come.

Are lab tests required?
▼

Yes — lab tests are required to proceed with men’s hormone treatment. We offer an extensive panel for $150; call us to schedule your draw time. If you already have labs of your own, make sure they include Total Testosterone, Free Testosterone, PSA, and a Complete Blood Count. If those labs are no more than 90 days old and cover this panel, we’ll waive the lab fee during your initial exam and consultation.

Where is MedClub located?
▼

333 Southern Blvd, Suite 404, West Palm Beach, FL 33405. Call (561) 214-3323 to schedule a consultation.

Important Disclosures

These statements have not been evaluated by the FDA. This article is provided for general educational purposes only and is not medical advice or a substitute for individualized evaluation. Compounded testosterone in MCT oil is not FDA-approved and has not been evaluated by the FDA for safety, efficacy, or quality.

Subcutaneous administration of testosterone is not an FDA-approved delivery route. MedClub does not recommend this route as a general practice; any discussion of technique here reflects internal clinical findings shared with patients already under direct provider care, not instructions for unsupervised self-administration.

TRT is a prescription treatment requiring an in-person medical evaluation and ongoing physician oversight. MedClub’s telehealth model applies to vitamins and peptide therapies, not to testosterone or other controlled substances. Individual results and appropriate treatment vary by patient. Pricing is approximate and subject to change.

Amino Acid Testing: Uncovering Your Nutritional Gaps

Amino acids are the building blocks of life, playing an essential role in muscle building, immune function, hormone regulation, and neurotransmitter production. Yet many of us overlook the importance of a balanced amino acid profile — unaware that imbalances or deficiencies can be connected to fatigue, digestive discomfort, and performance-related challenges.

That’s where MedClub’s Amino Acid Nutrition Testing Kit comes in — a simple, mail-in urinalysis kit that offers insight into your body’s nutritional needs. In this post, we’ll explore how amino acid testing can help identify nutritional gaps and support performance goals.

1. Nutritional Patterns Worth Discussing With Your Provider

Amino acid levels reflect more than just diet — testing can reveal patterns worth exploring further with your healthcare provider as part of your broader clinical picture. Some patients pursue this testing in connection with fatigue, digestive concerns, or general nutritional optimization; others use it in connection with broader neurological and mood-related concerns, always in consultation with their provider. Getting a clearer picture of your amino acid profile gives you and your provider more information to work with when addressing symptoms — not a standalone diagnosis, but one more piece of the picture.

2. Finding Nutritional Gaps: Tailoring Your Diet for Optimal Health

Even with a healthy diet, you might still be missing key amino acids your body needs to function at its best. A typical Western diet can lead to imbalances in essential amino acids necessary for muscle maintenance, immune support, and mental clarity. Vegetarians, vegans, and those with food sensitivities may be especially prone to gaps in certain amino acids.

MedClub’s testing kit provides an opportunity to identify these gaps. If your results show a potential deficiency, addressing it isn’t always as simple as adding more protein — each amino acid plays a specific role in metabolism, detoxification, and energy production, so a balanced intake across all essential amino acids matters. Understanding your individual profile lets you and your provider customize your diet or explore supplementation more precisely than general dietary advice alone.

3. Supporting Performance and Recovery

Whether you’re an athlete or simply looking to feel more energetic day to day, amino acids play a role in muscle function, stamina, and recovery. Branched-chain amino acids (BCAAs) — leucine, isoleucine, and valine — are involved in muscle repair and recovery; low levels on a test may be one factor among several worth discussing if you’re experiencing prolonged soreness or slower recovery. Arginine and ornithine are involved in nitric oxide production and circulation, which can relate to endurance. Testing gives you and your provider more information to work with when optimizing your nutrition around your performance goals.

4. The Convenience of MedClub’s Mail-In Kit

One of the standout features of this kit is convenience. Patients can order through MedClub’s telemedicine portal, collect a sample at home, and mail it in for analysis — no office visit required for the testing itself. Prefer to talk it through first? You’re welcome to come into the clinic to consult about the kit in person, or call us to schedule a telemedicine consultation.

Once processed, you’ll receive a report outlining your amino acid levels, which our clinical team reviews with you along with any recommended dietary or supplemental adjustments. Some patients also choose to bring their results to specialist appointments as supplementary information alongside their other clinical workup.

Conclusion

Amino acid testing is a useful tool for uncovering hidden nutritional gaps and supporting performance goals. With MedClub’s Amino Acid Nutrition Testing Kit, you can access a detailed breakdown of your amino acid profile from the comfort of your home — one more piece of information to bring to your care team as you work toward your health goals.

Important Disclosures

This article is provided for general educational and informational purposes only. The Amino Acid Nutrition Testing Kit has not been cleared or approved by the FDA; it is a laboratory-developed test performed by a CLIA-certified laboratory, intended for informational and nutritional guidance purposes.

This test is not intended to diagnose, treat, cure, or prevent any disease, and is not a substitute for clinical medical advice or diagnosis. It does not diagnose diabetes, kidney disease, neurological conditions, depression, anxiety, or any other specific medical or psychiatric condition. Results should always be reviewed with a qualified healthcare provider in the context of your full clinical picture — not as a standalone diagnostic tool.

BPC-157 vs. TB-500: What the Research Shows

Originally published 9/3/2024 · Updated 10/6/2026

BPC-157 and TB-500 are two research peptides that come up often in conversations about tissue biology. Both are investigational. Neither is FDA-approved for any use, and most of what is known about them comes from laboratory and animal studies. This article explains what each one is, what has been studied, and what remains unknown.

At a Glance

Two Names, Often Confused

Online, “TB-500” and “thymosin beta-4” are often treated as the same thing. They are not. Thymosin beta-4 (also called timbetasin) is a 43-amino-acid peptide that occurs naturally in the body. TB-500 is a much shorter, synthetic piece of it: about seven amino acids. Findings about one do not automatically apply to the other, and clinical trials of thymosin beta-4 used the full-length peptide^[2][3].

What the Evidence Can — and Can’t — Tell Us

Our Perspective

This section is editorial, not FDA policy. We believe patients are best served by clear information about what is and is not known. If you come across BPC-157, TB-500, or timbetasin from any source, we suggest asking three questions:

1. Which exact molecule is in the product? Names are used loosely, as the table above shows.
2. Where was it made, and what third-party testing was done?
3. What is its regulatory status, and what does the evidence show for the intended use?

Safety Considerations
▼

• Not FDA-approved; compounding restricted. Regulatory status may change as FDA rule-making proceeds.
• No human clinical safety data for BPC-157 were found in a 2025 systematic review^[1].
• “Research Use Only” and unlicensed sources carry risks of wrong contents, wrong dose, contamination, or no sterility testing.
• Injectable products can cause injection-site reactions and, rarely, severe allergic reactions. Seek emergency care for hives, wheezing, difficulty breathing, or swelling of the face, lips, tongue, or throat.
• Pregnancy, breastfeeding, and cancer history: research on tissue-growth pathways is a reason for caution. Discuss with a licensed clinician.
• Athletes: BPC-157 and thymosin beta-4 derivatives, including TB-500, appear on the WADA prohibited list.

Referenced Research